comparemela.com

Biogen And Eisai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We must temper celebrations over the new Alzheimer s drug

Biogen and Eisai caused a stir in September when they announced positive results in a late-stage trial for an Alzheimer’s drug, lecanemab

Alzheimer s drug slows disease in breakthrough trial

Biogen Inc. and partner Eisai Co said their experimental drug lecanemab significantly slowed the disease, making it the first medicine to blunt progression of the most common dementia in a large definitive study

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.